Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Statistics

Total Valuation

DNLI has a market cap or net worth of $2.81 billion. The enterprise value is $1.98 billion.

Market Cap	2.81B
Enterprise Value	1.98B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026, after market close.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

DNLI has 156.16 million shares outstanding. The number of shares has increased by 9.46% in one year.

Current Share Class	156.16M
Shares Outstanding	156.16M
Shares Change (YoY)	+9.46%
Shares Change (QoQ)	+0.57%
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	90.87%
Float	141.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	247.69
PB Ratio	2.85
P/TBV Ratio	3.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.79, with a Debt / Equity ratio of 0.05.

Current Ratio	9.79
Quick Ratio	9.43
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-782.60

Financial Efficiency

Return on equity (ROE) is -44.44% and return on invested capital (ROIC) is -29.24%.

Return on Equity (ROE)	-44.44%
Return on Assets (ROA)	-27.29%
Return on Invested Capital (ROIC)	-29.24%
Return on Capital Employed (ROCE)	-56.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	422
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DNLI has paid $68,000 in taxes.

Income Tax	68,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.33% in the last 52 weeks. The beta is 1.05, so DNLI's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	-16.33%
50-Day Moving Average	17.50
200-Day Moving Average	15.26
Relative Strength Index (RSI)	54.98
Average Volume (20 Days)	1,350,481

Short Selling Information

The latest short interest is 14.56 million, so 9.32% of the outstanding shares have been sold short.

Short Interest	14.56M
Short Previous Month	13.09M
Short % of Shares Out	9.32%
Short % of Float	10.26%
Short Ratio (days to cover)	8.69

Income Statement

Revenue	n/a
Gross Profit	-420.66M
Operating Income	-547.82M
Pretax Income	-498.68M
Net Income	-498.74M
EBITDA	-542.07M
EBIT	-547.82M
Earnings Per Share (EPS)	-$2.91

Balance Sheet

The company has $848.20 million in cash and $44.48 million in debt, with a net cash position of $828.43 million or $5.31 per share.

Cash & Cash Equivalents	848.20M
Total Debt	44.48M
Net Cash	828.43M
Net Cash Per Share	$5.31
Equity (Book Value)	926.20M
Book Value Per Share	6.32
Working Capital	792.45M

Cash Flow

In the last 12 months, operating cash flow was -$397.78 million and capital expenditures -$13.07 million, giving a free cash flow of -$410.85 million.

Operating Cash Flow	-397.78M
Capital Expenditures	-13.07M
Free Cash Flow	-410.85M
FCF Per Share	-$2.63

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DNLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.46%
Shareholder Yield	-9.46%
Earnings Yield	-17.75%
FCF Yield	-14.62%

Analyst Forecast

The average price target for DNLI is $31.58, which is 75.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.58
Price Target Difference	75.54%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1